Mahler DA - Search Results

1

Minimal important difference of the transition dyspnoea index in a multinational clinical trial.

Witek TJ Jr, Mahler DA. Witek TJ Jr, et al. Among authors: mahler da. Eur Respir J. 2003 Feb;21(2):267-72. doi: 10.1183/09031936.03.00068503a. Eur Respir J. 2003. PMID: 12608440 Free article.

2

Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD.

Ayers ML, Mejia R, Ward J, Lentine T, Mahler DA. Ayers ML, et al. Among authors: mahler da. Eur Respir J. 2001 Jun;17(6):1132-7. doi: 10.1183/09031936.01.00088801. Eur Respir J. 2001. PMID: 11491155 Free article. Clinical Trial.

3

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr. Casaburi R, et al. Among authors: mahler da. Eur Respir J. 2002 Feb;19(2):217-24. doi: 10.1183/09031936.02.00269802. Eur Respir J. 2002. PMID: 11866001 Free article. Clinical Trial.

4

Meaningful effect size and patterns of response of the transition dyspnea index.

Witek TJ Jr, Mahler DA. Witek TJ Jr, et al. Among authors: mahler da. J Clin Epidemiol. 2003 Mar;56(3):248-55. doi: 10.1016/s0895-4356(02)00589-9. J Clin Epidemiol. 2003. PMID: 12725879 Clinical Trial.

5

The MCID of the transition dyspnea index is a total score of one unit.

Mahler DA, Witek TJ Jr. Mahler DA, et al. COPD. 2005 Mar;2(1):99-103. doi: 10.1081/copd-200050666. COPD. 2005. PMID: 17136969 Review.

6

Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD.

Mahler DA, Murray JA, Waterman LA, Ward J, Kraemer WJ, Zhang X, Baird JC. Mahler DA, et al. Eur Respir J. 2009 Apr;33(4):771-7. doi: 10.1183/09031936.00145208. Epub 2009 Feb 12. Eur Respir J. 2009. PMID: 19213787 Free article. Clinical Trial.

7

Prevalence and clinical correlates of bronchoreversibility in severe emphysema.

Han MK, Wise R, Mumford J, Sciurba F, Criner GJ, Curtis JL, Murray S, Sternberg A, Weinman G, Kazerooni E, Fishman AP, Make B, Hoffman EA, Mosenifar Z, Martinez FJ; NETT Research Group. Han MK, et al. Eur Respir J. 2010 May;35(5):1048-56. doi: 10.1183/09031936.00052509. Epub 2009 Nov 19. Eur Respir J. 2010. PMID: 19926748 Free article. Clinical Trial.

8

Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD.

Jones PW, Mahler DA, Gale R, Owen R, Kramer B. Jones PW, et al. Among authors: mahler da. Respir Med. 2011 Jun;105(6):892-9. doi: 10.1016/j.rmed.2011.02.013. Epub 2011 Mar 11. Respir Med. 2011. PMID: 21397482 Free article. Clinical Trial.

9

Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study.

Mahler DA, Decramer M, D'Urzo A, Worth H, White T, Alagappan VK, Chen H, Gallagher N, Kulich K, Banerji D. Mahler DA, et al. Eur Respir J. 2014 Jun;43(6):1599-609. doi: 10.1183/09031936.00124013. Epub 2013 Oct 31. Eur Respir J. 2014. PMID: 24176997 Free article. Clinical Trial.

10

Prospective validation of the endurance shuttle walking test in the context of bronchodilation in COPD.

Borel B, Pepin V, Mahler DA, Nadreau É, Maltais F. Borel B, et al. Among authors: mahler da. Eur Respir J. 2014 Nov;44(5):1166-76. doi: 10.1183/09031936.00024314. Epub 2014 Sep 3. Eur Respir J. 2014. PMID: 25186261 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page